Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors that is currently under clinical development by ReComBio...
9 KB (952 words) - 13:36, 31 March 2024
to their target antigen. An example of an anti-idiotype antibody is Racotumomab. To produce an anti-idiotypic vaccine, antibodies that bind tumor-associated...
2 KB (255 words) - 22:17, 23 August 2022
racemorphan (INN) racephedrine (INN) racepinefrine (INN) raclopride (INN) racotumomab (INN) ractalind (INN) ractopamine (INN) radafaxine (USAN) radavirsen...
5 KB (286 words) - 04:52, 6 September 2024
Therapies developed the first therapeutic vaccine against lung cancer, Racotumomab (Vaxira), introduced in 2013. Inspired by that model, other partnerships...
18 KB (1,775 words) - 22:56, 9 February 2024
140 humanized CCR5 HIV infection Quilizumab mab humanized IGHE asthma Racotumomab Vaxira mab mouse NGNA ganglioside Y non-small cell lung cancer Radretumab...
136 KB (4,020 words) - 06:13, 27 September 2024
of nivolumab. As of 2023, accural for this phase II trial is ongoing. Racotumomab "RESOLUCIÓN No. 2016006539 DE 25 de Febrero de 2016 Por la cual se concede...
16 KB (1,556 words) - 23:09, 17 July 2024
Moxetumomab pasudotox Naptumomab estafenatox Oregovomab Pemtumomab† Racotumomab Satumomab pendetide Solitomab Taplitumomab paptox Nofetumomab merpentan...
5 KB (368 words) - 15:29, 21 August 2024
lung cancer 2012 – Cuba develops and releases monoclonal antibody, Racotumomab, the therapeutic cancer vaccine for lung cancer 2015 – US FDA approves...
27 KB (2,580 words) - 18:15, 7 September 2023
Moxetumomab pasudotox Naptumomab estafenatox Oregovomab Pemtumomab† Racotumomab Satumomab pendetide Solitomab Taplitumomab paptox Nofetumomab merpentan...
4 KB (241 words) - 13:42, 14 July 2024
therapeutic cancer vaccine was approved by Cuban regulatory agency. CIMAbid (racotumomab or 1E10)obtained conditional approval for the treatment of lung cancer...
5 KB (585 words) - 08:54, 5 April 2024
Moxetumomab pasudotox Naptumomab estafenatox Oregovomab Pemtumomab† Racotumomab Satumomab pendetide Solitomab Taplitumomab paptox Nofetumomab merpentan...
3 KB (129 words) - 01:04, 19 July 2023